Stevens Capital Management LP lowered its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 59.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 46,544 shares of the technology company’s stock after selling 68,094 shares during the quarter. Stevens Capital Management LP’s holdings in Amdocs were worth $2,890,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. FMR LLC lifted its position in shares of Amdocs by 12.1% during the 1st quarter. FMR LLC now owns 20,412,323 shares of the technology company’s stock valued at $1,104,510,000 after acquiring an additional 2,203,154 shares during the period. Janus Henderson Group PLC raised its holdings in shares of Amdocs by 1.9% during the 2nd quarter. Janus Henderson Group PLC now owns 7,714,259 shares of the technology company’s stock worth $478,979,000 after buying an additional 141,055 shares in the last quarter. Wells Fargo & Company MN raised its holdings in shares of Amdocs by 28.1% during the 1st quarter. Wells Fargo & Company MN now owns 5,951,683 shares of the technology company’s stock worth $322,045,000 after buying an additional 1,303,903 shares in the last quarter. Beutel Goodman & Co Ltd. raised its holdings in shares of Amdocs by 41.9% during the 1st quarter. Beutel Goodman & Co Ltd. now owns 2,918,932 shares of the technology company’s stock worth $118,189,000 after buying an additional 862,601 shares in the last quarter. Finally, Nordea Investment Management AB raised its holdings in shares of Amdocs by 28.9% during the 1st quarter. Nordea Investment Management AB now owns 2,867,827 shares of the technology company’s stock worth $155,177,000 after buying an additional 643,331 shares in the last quarter. 90.70% of the stock is currently owned by institutional investors.
Shares of Amdocs stock traded up $0.45 on Thursday, hitting $63.45. 63,709 shares of the company’s stock traded hands, compared to its average volume of 589,255. Amdocs Limited has a one year low of $52.60 and a one year high of $67.57. The firm’s fifty day moving average price is $63.20. The company has a market cap of $8.88 billion, a P/E ratio of 16.97, a price-to-earnings-growth ratio of 1.85 and a beta of 0.41.
Amdocs (NASDAQ:DOX) last announced its earnings results on Wednesday, August 7th. The technology company reported $1.19 EPS for the quarter, beating the consensus estimate of $1.11 by $0.08. Amdocs had a return on equity of 15.73% and a net margin of 9.90%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the company earned $1.03 EPS. The firm’s revenue for the quarter was up 2.2% compared to the same quarter last year. Equities research analysts expect that Amdocs Limited will post 4.05 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a $0.285 dividend. This represents a $1.14 annualized dividend and a dividend yield of 1.80%. The ex-dividend date of this dividend is Friday, September 27th. Amdocs’s dividend payout ratio (DPR) is presently 30.48%.
A number of equities analysts have recently commented on the company. Zacks Investment Research cut Amdocs from a “buy” rating to a “hold” rating and set a $67.00 price target for the company. in a report on Tuesday, July 16th. ValuEngine raised Amdocs from a “sell” rating to a “hold” rating in a report on Wednesday, May 15th. BidaskClub raised Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, August 10th. TheStreet raised Amdocs from a “c+” rating to a “b-” rating in a report on Tuesday, June 4th. Finally, JPMorgan Chase & Co. upped their target price on Amdocs from $67.00 to $75.00 and gave the stock a “neutral” rating in a report on Thursday, August 8th. Three equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $71.00.
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.
Featured Article: Analyst Ratings Trading
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.